Home
EN / FR

Celyad Oncology

Home / Investors / Shareholders Information

Shareholders Information

Shareholders Information

Equity Threshold (as of December 8, 2021)

EQUITY_2_12.8

Voting Threshold (as of December 8, 2021)

VOTING

Total Number of Shares And Voting Rights

Total amount of share capital (EUR) (as of December 8, 2021) 78,584,224.33
Total number of shares with single voting rights (as of December 8, 2021) 20,225,931
Total number of shares with double voting rights (as of December 8, 2021) 2,368,025
Total number of shares (as of December 8, 2021) 22,593,956
Total number of voting rights (as of December 8, 2021) 24,961,981
Total number of attributed warrants (as of December 8, 2021) 1,997,190
Total number of shares with voting rights that could be created following the exercise of the attributed warrants (as of December 8, 2021) 1,997,190
Total number of diluted shares (outstanding shares + warrants) (as of December 8, 2021) 24,591,146
Total number of diluted shares with voting rights (as of December 8, 2021) 26,959,171

Transparency Declarations

17 Dec 2021 Tolefi SA
13 Dec 2021 Fortress Investment Group LLC
19 May 2021 Victory Capital Management Inc.
05 May 2021 Tolefi SA
28 Sep 2018 Victory Capital Management Inc.
01 Jun 2018 Tolefi SA
17 Feb 2017 Tolefi SA
03 Aug 2016 Medisun International Ltd and National Fund Ltd
29 Jun 2015 PMV-TINA
29 Jun 2015 SRIW SA
05 Mar 2015 Tolefi SA
20 Aug 2014 Tolefi SA
12 Jul 2013 Tolefi SA, PMV NV, SRIW SA/ Sofipole SA, Mayo Foundation

Investor Contact Information:

Sara Zelkovic

Communications and IR Director

Investors@celyad.com